AU1759499A - Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors - Google Patents
Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitorsInfo
- Publication number
- AU1759499A AU1759499A AU17594/99A AU1759499A AU1759499A AU 1759499 A AU1759499 A AU 1759499A AU 17594/99 A AU17594/99 A AU 17594/99A AU 1759499 A AU1759499 A AU 1759499A AU 1759499 A AU1759499 A AU 1759499A
- Authority
- AU
- Australia
- Prior art keywords
- lanesterol
- epoxysqualene
- azacycloalkanes
- thio
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Cardiology (AREA)
- Food Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19754796A DE19754796A1 (en) | 1997-12-10 | 1997-12-10 | Novel azacycloalkane-derived urethanes, their thio and dithio analogues, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation |
DE19754796 | 1997-12-10 | ||
PCT/EP1998/007965 WO1999029669A1 (en) | 1997-12-10 | 1998-12-08 | Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1759499A true AU1759499A (en) | 1999-06-28 |
Family
ID=7851381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17594/99A Abandoned AU1759499A (en) | 1997-12-10 | 1998-12-08 | Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1060162B1 (en) |
JP (1) | JP3418688B2 (en) |
KR (1) | KR20010032977A (en) |
CN (1) | CN1281434A (en) |
AR (1) | AR017827A1 (en) |
AT (1) | ATE234816T1 (en) |
AU (1) | AU1759499A (en) |
BG (1) | BG104500A (en) |
BR (1) | BR9813495A (en) |
CA (1) | CA2309388A1 (en) |
CO (1) | CO5370694A1 (en) |
DE (2) | DE19754796A1 (en) |
DK (1) | DK1060162T3 (en) |
EA (1) | EA200000631A1 (en) |
EE (1) | EE200000342A (en) |
ES (1) | ES2190130T3 (en) |
HR (1) | HRP20000377A2 (en) |
HU (1) | HUP0100335A3 (en) |
IL (1) | IL135738A0 (en) |
NO (1) | NO20002967L (en) |
PL (1) | PL341060A1 (en) |
PT (1) | PT1060162E (en) |
SK (1) | SK8612000A3 (en) |
TR (1) | TR200001635T2 (en) |
WO (1) | WO1999029669A1 (en) |
YU (1) | YU35600A (en) |
ZA (1) | ZA9811262B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002055495A1 (en) * | 2001-01-15 | 2002-07-18 | Glaxo Group Limited | Aryl piperidine derivatives as inducers of ldl-receptor expression |
WO2002055497A1 (en) * | 2001-01-15 | 2002-07-18 | Glaxo Group Limited | Aryl piperidine derivatives as inducers of ldl-receptor expression |
US20040077654A1 (en) * | 2001-01-15 | 2004-04-22 | Bouillot Anne Marie Jeanne | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
DE10132686A1 (en) * | 2001-07-05 | 2003-01-16 | Boehringer Ingelheim Pharma | Heteroarylcarboxamides, their preparation and their use as medicines |
JP4664634B2 (en) * | 2003-09-05 | 2011-04-06 | 富山化学工業株式会社 | Novel benzamidine derivatives or salts thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04312572A (en) * | 1991-04-12 | 1992-11-04 | Takeda Chem Ind Ltd | Cyclic amine compound |
DE4407138A1 (en) * | 1994-03-04 | 1995-09-07 | Thomae Gmbh Dr K | New (aminomethyl-benzyl(idene))-aza:cycloalkane carbonyl cpds. |
DE4407136A1 (en) * | 1994-03-04 | 1995-09-07 | Thomae Gmbh Dr K | New amino:methyl substd. aroyl-aza:cycloalkane derivs. |
-
1997
- 1997-12-10 DE DE19754796A patent/DE19754796A1/en not_active Withdrawn
-
1998
- 1998-12-08 ES ES98962423T patent/ES2190130T3/en not_active Expired - Lifetime
- 1998-12-08 EA EA200000631A patent/EA200000631A1/en unknown
- 1998-12-08 BR BR9813495-7A patent/BR9813495A/en not_active IP Right Cessation
- 1998-12-08 EP EP98962423A patent/EP1060162B1/en not_active Expired - Lifetime
- 1998-12-08 WO PCT/EP1998/007965 patent/WO1999029669A1/en not_active Application Discontinuation
- 1998-12-08 DK DK98962423T patent/DK1060162T3/en active
- 1998-12-08 IL IL13573898A patent/IL135738A0/en unknown
- 1998-12-08 KR KR1020007006326A patent/KR20010032977A/en not_active Application Discontinuation
- 1998-12-08 HU HU0100335A patent/HUP0100335A3/en unknown
- 1998-12-08 TR TR2000/01635T patent/TR200001635T2/en unknown
- 1998-12-08 CN CN98811959A patent/CN1281434A/en active Pending
- 1998-12-08 CA CA002309388A patent/CA2309388A1/en not_active Abandoned
- 1998-12-08 YU YU35600A patent/YU35600A/en unknown
- 1998-12-08 EE EEP200000342A patent/EE200000342A/en unknown
- 1998-12-08 SK SK861-2000A patent/SK8612000A3/en unknown
- 1998-12-08 AT AT98962423T patent/ATE234816T1/en not_active IP Right Cessation
- 1998-12-08 DE DE59807591T patent/DE59807591D1/en not_active Expired - Fee Related
- 1998-12-08 PT PT98962423T patent/PT1060162E/en unknown
- 1998-12-08 PL PL98341060A patent/PL341060A1/en unknown
- 1998-12-08 AU AU17594/99A patent/AU1759499A/en not_active Abandoned
- 1998-12-08 JP JP2000524266A patent/JP3418688B2/en not_active Expired - Fee Related
- 1998-12-09 ZA ZA9811262A patent/ZA9811262B/en unknown
- 1998-12-09 CO CO98073126A patent/CO5370694A1/en not_active Application Discontinuation
- 1998-12-09 AR ARP980106228A patent/AR017827A1/en not_active Withdrawn
-
2000
- 2000-06-02 BG BG104500A patent/BG104500A/en active Pending
- 2000-06-07 HR HR20000377A patent/HRP20000377A2/en not_active Application Discontinuation
- 2000-06-09 NO NO20002967A patent/NO20002967L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010032977A (en) | 2001-04-25 |
IL135738A0 (en) | 2001-05-20 |
PT1060162E (en) | 2003-08-29 |
YU35600A (en) | 2002-09-19 |
CN1281434A (en) | 2001-01-24 |
DK1060162T3 (en) | 2003-07-14 |
HUP0100335A2 (en) | 2001-07-30 |
EP1060162B1 (en) | 2003-03-19 |
PL341060A1 (en) | 2001-03-26 |
TR200001635T2 (en) | 2000-11-21 |
NO20002967D0 (en) | 2000-06-09 |
DE59807591D1 (en) | 2003-04-24 |
JP2001525397A (en) | 2001-12-11 |
EP1060162A1 (en) | 2000-12-20 |
CO5370694A1 (en) | 2004-02-27 |
CA2309388A1 (en) | 1999-06-17 |
HUP0100335A3 (en) | 2001-11-28 |
ATE234816T1 (en) | 2003-04-15 |
ZA9811262B (en) | 2000-06-09 |
EA200000631A1 (en) | 2000-12-25 |
BG104500A (en) | 2001-03-30 |
NO20002967L (en) | 2000-08-09 |
WO1999029669A1 (en) | 1999-06-17 |
HRP20000377A2 (en) | 2000-12-31 |
JP3418688B2 (en) | 2003-06-23 |
ES2190130T3 (en) | 2003-07-16 |
DE19754796A1 (en) | 1999-06-17 |
SK8612000A3 (en) | 2000-11-07 |
BR9813495A (en) | 2000-10-10 |
EE200000342A (en) | 2001-08-15 |
AR017827A1 (en) | 2001-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7100298A (en) | Thio derivatives as naaladase inhibitors | |
AU4006800A (en) | 1,2-dithiolane derivatives | |
EP1002559B8 (en) | Gun-shaped controller | |
AU1730497A (en) | Fungicidal 1,2,4-oxadiazoles and analogues | |
AU5707294A (en) | 3,3 diphenyl prop-2-yl amino acid derivatives and their use as tachykinin antagonists | |
AU6026098A (en) | Sulfur removal process | |
AU3053495A (en) | 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives | |
AU1854895A (en) | Modifying nucleotide analogues | |
AU3539199A (en) | Novel 2,5-pyridinedicarboxylic acid derivatives | |
AU6287998A (en) | Spray head | |
AU1332295A (en) | Analogues of hgh-rh (1-29)nh2 having antagonistic activity | |
AU4486696A (en) | Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides | |
AU1759499A (en) | Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors | |
IL141850A (en) | High purity composition comprising (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-3n-20-yn-3-one | |
AU8238698A (en) | A decorator's tool | |
AU1094197A (en) | Carbamic acid derivatives as leukotriene antagonists | |
AU6014398A (en) | Low environmental toxicity latex coatings | |
SI1060162T1 (en) | Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors | |
AU3062200A (en) | Sulphur removal | |
AU6277699A (en) | Guarantee 20 | |
AU1759399A (en) | Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof | |
AU2092797A (en) | Substituted thienylsulphonyl (thio) ureas as herbicides | |
AU2645199A (en) | Dialkyl-1-aryl-1-(2,4-dioxo-5-amino-1,3-pyrimidin-5-yl)methy lphosphonates | |
AU6418396A (en) | Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide | |
AU9029898A (en) | 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |